BRIMS, MGH Scientists Partnering to Identify Protein Biomarkers Linked to Stroke | GenomeWeb

Researchers at Thermo Fisher Scientific's BRIMS Center are working with scientists at Massachusetts General Hospital to identify protein biomarkers linked to stroke.

The work, which uses a new biomarker-discovery workflow under development at BRIMS, aims to find markers to improve stroke patients' treatment options and shed light onto the biological mechanisms underlying the disease, said project co-leader MingMing Ning, a scientist at MGH's Clinical Proteomics Research Center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.